Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Impact of the Combinations of Allergic Diseases on Myocardial Infarction and Mortality

Authors
Rhee, T.-M.Choi, E.-K.Han, K.-D.Lee, S.-R.Oh, S.
Issue Date
Feb-2021
Publisher
American Academy of Allergy, Asthma and Immunology
Keywords
Allergic rhinitis; Asthma; Atopic dermatitis; Mortality; Myocardial infarction
Citation
Journal of Allergy and Clinical Immunology: In Practice, v.9, no.2, pp.872 - 880.e4
Journal Title
Journal of Allergy and Clinical Immunology: In Practice
Volume
9
Number
2
Start Page
872
End Page
880.e4
URI
http://scholarworks.bwise.kr/ssu/handle/2018.sw.ssu/39746
DOI
10.1016/j.jaip.2020.09.008
ISSN
2213-2198
Abstract
Background: Allergic rhinitis (AR), atopic dermatitis (AD), and asthma, each by itself, are known to be associated with a higher risk of cardiovascular disease. Each of these diseases often coexists with one another, but the effect of combined allergic diseases on the long-term risk of myocardial infarction (MI) and mortality remains unknown. Objective: To evaluate the effects of various combinations of the allergic triad on the risk of MI and mortality. Methods: Adult allergic disease patients without prior MI were enrolled from the nationwide health check-up data provided by the Korean National Health Insurance Service in 2009. The primary and secondary end points were all-cause death and MI. Results: A total of 9,548,939 individuals older than 20 years were selected for analysis. The prevalence of allergic diseases was 13.9% for AR, 0.4% for AD, and 2.7% for asthma. During a median 8.2 years of follow-up, 105,659 MIs and 298,769 deaths occurred. All allergic diseases were associated with an increased risk of MI (AR, adjusted hazard ratio [HRadjust], 1.11, 95% CI, 1.10-1.13; AD, HRadjust, 1.14, 95% CI, 1.06-1.24; asthma, HRadjust, 1.37, 95% CI, 1.33-1.40), whereas mortality risk was increased only for patients with AD (HRadjust, 1.15; 95% CI, 1.10-1.20) or asthma (HRadjust, 1.41; 95% CI, 1.39-1.43). Among the combinations of allergic diseases, patients with both AD and asthma had the highest risk of mortality (HRadjust, 1.71; 95% CI, 1.46-2.00) and MI (HRadjust, 1.57; 95% CI, 1.15-2.16). The results were significant after adjusting for demographic characteristics, comorbidities, socioeconomic status, and lifestyle factors. Conclusions: Patients with both AD and asthma have the highest risk of MI and mortality among all allergic disease combinations. Physicians should evaluate combinations of allergic conditions in allergic disease patients and promptly assess and manage their future risk of MI and mortality. © 2020 American Academy of Allergy, Asthma & Immunology
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Natural Sciences > ETC > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Han, Kyungdo photo

Han, Kyungdo
College of Natural Sciences (Department of Statistics and Actuarial Science)
Read more

Altmetrics

Total Views & Downloads

BROWSE